keyword
https://read.qxmd.com/read/38656555/the-involvement-of-ripk4-in-tnf-%C3%AE-stimulated-il-6-and-il-8-production-by-melanoma-cells
#41
JOURNAL ARTICLE
Ewelina Madej, Anna Lisek, Anna A Brożyna, Agnieszka Cierniak, Norbert Wronski, Milena Deptula, Anna Wardowska, Agnieszka Wolnicka-Glubisz
PURPOSE: The receptor-interacting protein kinase (RIPK4) has an oncogenic function in melanoma, regulates NF-κB and Wnt/β-catenin pathways, and is sensitive to the BRAF inhibitors: vemurafenib and dabrafenib which lead to its decreased level. As its role in melanoma remains not fully understood, we examined the effects of its downregulation on the transcriptomic profile of melanoma. METHODS: Applying RNA-seq, we revealed global alterations in the transcriptome of WM266...
April 24, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38656520/dual-luciferase-reporter-assay-for-prescreening-crispr-d-cas9-mediated-epigenetic-editing-on-a-plant-promoter-using-human-cells
#42
JOURNAL ARTICLE
Ann-Kathrin Hinrichs, Aline Koch, Antje M Richter
Epigenetic editing, also known as EpiEdit, offers an exciting way to control gene expression without altering the DNA sequence. In this study, we evaluate the application of EpiEdit to plant promoters, specifically the MLO (mildew locus o) gene promoter. We use a modified CRISPR-(d)Cas9 system, in which the nuclease-deficient Cas9 (dCas9) is fused to an epigenetic modifier, to experimentally demonstrate the utility of this tool for optimizing epigenetic engineering of a plant promoter prior to in vivo plant epigenome editing...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38656412/creating-a-zero-amylose-barley-with-high-soluble-sugar-content-by-genome-editing
#43
JOURNAL ARTICLE
Yun Li, Yanyan Jiang, Dong Cao, Bin Dang, Xijuan Yang, Shiting Fan, Yuhu Shen, Genying Li, Baolong Liu
Amylose biosynthesis is strictly associated with granule-bound starch synthase I (GBSSI) encoded by the Waxy gene. Mutagenesis of single bases in the Waxy gene, which induced by CRISPR/Cas9 genome editing, caused absence of intact GBSSI protein in grain of the edited line. The amylose and amylopectin contents of waxy mutants were zero and 31.73%, while those in the wild type were 33.50% and 39.00%, respectively. The absence of GBSSI protein led to increase in soluble sugar content to 37.30% compared with only 10...
April 24, 2024: Plant Molecular Biology
https://read.qxmd.com/read/38653965/targeting-nras-via-mir-1304-5p-or-farnesyltransferase-inhibition-confers-sensitivity-to-alk-inhibitors-in-alk-mutant-neuroblastoma
#44
JOURNAL ARTICLE
Perla Pucci, Liam C Lee, Miaojun Han, Jamie D Matthews, Leila Jahangiri, Michaela Schlederer, Eleanor Manners, Annabel Sorby-Adams, Joshua Kaggie, Ricky M Trigg, Christopher Steel, Lucy Hare, Emily R James, Nina Prokoph, Stephen P Ducray, Olaf Merkel, Firkret Rifatbegovic, Ji Luo, Sabine Taschner-Mandl, Lukas Kenner, G A Amos Burke, Suzanne D Turner
Targeting Anaplastic lymphoma kinase (ALK) is a promising therapeutic strategy for aberrant ALK-expressing malignancies including neuroblastoma, but resistance to ALK tyrosine kinase inhibitors (ALK TKI) is a distinct possibility necessitating drug combination therapeutic approaches. Using high-throughput, genome-wide CRISPR-Cas9 knockout screens, we identify miR-1304-5p loss as a desensitizer to ALK TKIs in aberrant ALK-expressing neuroblastoma; inhibition of miR-1304-5p decreases, while mimics of this miRNA increase the sensitivity of neuroblastoma cells to ALK TKIs...
April 23, 2024: Nature Communications
https://read.qxmd.com/read/38653778/lineage-specific-transcription-factor-waves-reprogram-neuroblastoma-from-self-renewal-to-differentiation
#45
JOURNAL ARTICLE
Deblina Banerjee, Sukriti Bagchi, Zhihui Liu, Hsien-Chao Chou, Man Xu, Ming Sun, Sara Aloisi, Zalman Vaksman, Sharon J Diskin, Mark Zimmerman, Javed Khan, Berkley Gryder, Carol J Thiele
Temporal regulation of super-enhancer (SE) driven transcription factors (TFs) underlies normal developmental programs. Neuroblastoma (NB) arises from an inability of sympathoadrenal progenitors to exit a self-renewal program and terminally differentiate. To identify SEs driving TF regulators, we use all-trans retinoic acid (ATRA) to induce NB growth arrest and differentiation. Time-course H3K27ac ChIP-seq and RNA-seq reveal ATRA coordinated SE waves. SEs that decrease with ATRA link to stem cell development (MYCN, GATA3, SOX11)...
April 23, 2024: Nature Communications
https://read.qxmd.com/read/38653348/role-of-pip39-in-oxidative-stress-response-appears-conserved-in-kinetoplastids
#46
JOURNAL ARTICLE
Hina Durrani, James A Bjork, Sara L Zimmer
Kinetoplastids, a group of flagellated protists that are often insect intestinal parasites, encounter various sources of oxidative stress. Such stressors include reactive oxygen species, both internally produced within the protist, and induced externally by host immune responses. This investigation focuses on the role of a highly conserved aspartate-based protein phosphatase, PTP-Interacting protein (PIP39) in managing oxidative stress. In addition to its well accepted role in a Trypanosoma brucei life stage transition, there is evidence of PIP39 participation in the T...
April 21, 2024: Molecular and Biochemical Parasitology
https://read.qxmd.com/read/38653245/integrated-drug-profiling-and-crispr-screening-identify-bcr-abl1-independent-vulnerabilities-in-chronic-myeloid-leukemia
#47
JOURNAL ARTICLE
Shady Adnan Awad, Olli Dufva, Jay Klievink, Ella Karjalainen, Aleksandr Ianevski, Paavo Pietarinen, Daehong Kim, Swapnil Potdar, Maija Wolf, Kourosh Lotfi, Tero Aittokallio, Krister Wennerberg, Kimmo Porkka, Satu Mustjoki
BCR::ABL1-independent pathways contribute to primary resistance to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) and play a role in leukemic stem cell persistence. Here, we perform ex vivo drug screening of CML CD34+ leukemic stem/progenitor cells using 100 single drugs and TKI-drug combinations and identify sensitivities to Wee1, MDM2, and BCL2 inhibitors. These agents effectively inhibit primitive CD34+ CD38- CML cells and demonstrate potent synergies when combined with TKIs...
April 10, 2024: Cell reports medicine
https://read.qxmd.com/read/38652202/developing-a-novel-enzalutamide-resistant-prostate-cancer-model-via-ar-f877l-mutation-in-lncap-cells
#48
JOURNAL ARTICLE
Ruifeng Wang, Shuhua Ma, Nengwei Xu, Yumiao Gan, Pengya Li, Jingying Zhang, Zhixiang Zhang, Qingyang Gu, Jian Xiang
Prostate cancer is a leading diagnosis and major cause of cancer-related deaths in men worldwide. As a typical hormone-responsive disease, prostate cancer is commonly managed with androgen deprivation therapy (ADT) to curb its progression and potential metastasis. Unfortunately, progression to castration-resistant prostate cancer (CRPC), a notably more aggressive phase of the disease, occurs within a timeframe of 2-3 years following ADT. Enzalutamide, a recognized androgen receptor (AR) antagonist, has been employed as a standard of care for men with metastatic castration-resistant prostate cancer (mCRPC) since it was first approved in 2012, due to its ability to prolong survival...
April 2024: Current protocols
https://read.qxmd.com/read/38652190/an-efficient-vector-based-crispr-cas9-system-in-zebrafish-cell-line
#49
JOURNAL ARTICLE
Xiaokang Ye, Jiali Lin, Qiuji Chen, Jiehuan Lv, Chunsheng Liu, Yuping Wang, Shuqi Wang, Xiaobo Wen, Fan Lin
The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system has been widely applied in animals as an efficient genome editing tool. However, the technique is difficult to implement in fish cell lines partially due to the lack of efficient promoters to drive the expression of both sgRNA and the Cas9 protein within a single vector. In this study, it was indicated that the zebrafish U6 RNA polymerase III (ZFU6) promoter could efficiently induce tyrosinase (tyr) gene editing and lead to loss of retinal pigments when co-injection with Cas9 mRNA in zebrafish embryo...
April 23, 2024: Marine Biotechnology
https://read.qxmd.com/read/38652106/endogenous-tagging-using-split-mneongreen-in-human-ipscs-for-live-imaging-studies
#50
JOURNAL ARTICLE
Mathieu C Husser, Nhat P Pham, Chris Law, Flavia R B Araujo, Vincent J J Martin, Alisa Piekny
Endogenous tags have become invaluable tools to visualize and study native proteins in live cells. However, generating human cell lines carrying endogenous tags is difficult due to the low efficiency of homology-directed repair. Recently, an engineered split mNeonGreen protein was used to generate a large-scale endogenous tag library in HEK293 cells. Using split mNeonGreen for large-scale endogenous tagging in human iPSCs would open the door to studying protein function in healthy cells and across differentiated cell types...
April 23, 2024: ELife
https://read.qxmd.com/read/38651266/integrated-machine-learning-and-multimodal-data-fusion-for-patho-phenotypic-feature-recognition-in-ipsc-models-of-dilated-cardiomyopathy
#51
JOURNAL ARTICLE
Ruheen Wali, Hang Xu, Cleophas Cheruiyot, Hafiza Nosheen Saleem, Andreas Janshoff, Michael Habeck, Antje Ebert
Integration of multiple data sources presents a challenge for accurate prediction of molecular patho-phenotypic features in automated analysis of data from human model systems. Here, we applied a machine learning-based data integration to distinguish patho-phenotypic features at the subcellular level for dilated cardiomyopathy (DCM). We employed a human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) model of a DCM mutation in the sarcomere protein troponin T (TnT), TnT-R141W, compared to isogenic healthy (WT) control iPSC-CMs...
April 24, 2024: Biological Chemistry
https://read.qxmd.com/read/38649857/a-tomato-nac-transcription-factor-slnap1-directly-regulates-gibberellin-dependent-fruit-ripening
#52
JOURNAL ARTICLE
Changxia Li, Xuemei Hou, Zongxi Zhao, Huwei Liu, Panpan Huang, Meimei Shi, Xuetong Wu, Rong Gao, Zhiya Liu, Lijuan Wei, Yihua Li, Weibiao Liao
In tomato (Solanum lycopersicum), the ripening of fruit is regulated by the selective expression of ripening-related genes, and this procedure is controlled by transcription factors (TFs). In the various plant-specific TF families, the no apical meristem (NAM), Arabidopsis thaliana activating factor 1/2 (ATAF1/2), and cup-shaped cotyledon 2 (CUC2; NAC) TF family stands out and plays a significant function in plant physiological activities, such as fruit ripening (FR). Despite the numerous genes of NAC found in the tomato genome, limited information is available on the effects of NAC members on FR, and there is also a lack of studies on their target genes...
April 23, 2024: Cellular & Molecular Biology Letters
https://read.qxmd.com/read/38648691/manganese-induces-podocyte-injury-through-regulating-mtdh-alkbh5-nlrp10-axis-combined-analysis-at-epidemiology-and-molecular-biology-levels
#53
JOURNAL ARTICLE
Qiuju Liang, Jiajun Jing, Huiming He, Xiaofeng Huang, Jianing Liu, Mingjun Wang, Zijuan Qi, Li'e Zhang, Ziang Huang, Yuanliang Yan, Sijin Liu, Ming Gao, Yunfeng Zou
Manganese (Mn) is an essential micronutrient required for various biological processes but excess exposure to Mn can cause neurotoxicity. However, there are few reports regarding the toxicity effect of Mn on the kidney as well as the underlying molecule mechanism. Herein, in vivo experiments were adopted to assess the toxicity effects associated with Mn, and found that chronic Mn treatment induced the injury of glomerular podocytes but not renal tubule in rats. Genome-wide CRISPR/Cas9 knockout screen was then employed to explore the biotargets of the toxic effect of Mn on podocytes...
April 18, 2024: Environment International
https://read.qxmd.com/read/38647391/magnetic-nanoparticle-assisted-non-viral-crispr-cas9-for-enhanced-genome-editing-to-treat-rett-syndrome
#54
JOURNAL ARTICLE
Hyeon-Yeol Cho, Myungsik Yoo, Thanapat Pongkulapa, Hudifah Rabie, Alysson R Muotri, Perry T Yin, Jeong-Woo Choi, Ki-Bum Lee
The CRISPR-Cas9 technology has the potential to revolutionize the treatment of various diseases, including Rett syndrome, by enabling the correction of genes or mutations in human patient cells. However, several challenges need to be addressed before its widespread clinical application. These challenges include the low delivery efficiencies to target cells, the actual efficiency of the genome-editing process, and the precision with which the CRISPR-Cas system operates. Herein, the study presents a Magnetic Nanoparticle-Assisted Genome Editing (MAGE) platform, which significantly improves the transfection efficiency, biocompatibility, and genome-editing accuracy of CRISPR-Cas9 technology...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38645014/increased-frequency-of-chd1-deletions-in-prostate-cancers-of-african-american-men-is-associated-with-rapid-disease-progression-without-inducing-homologous-recombination-deficiency
#55
Zoltan Szallasi, Miklos Diossy, Viktoria Tisza, Hua Li, Pranshu Sahgal, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nuosome, Claire Kuo, Jiji Jiang, Yongmei Chen, Reinhard Ebner, Isabell Sesterhenn, Joel Moncur, Gregory Chesnut, Gyorgy Petrovics, Gregory T Klus, Gábor Valcz, Pier Nuzzo, Dezso Ribli, Judit Börcsök, Aurél Prósz, Marcin Krzystanek, Thomas Ried, Dávid Szüts, Kinza Rizwan, Salma Kaochar, Shailja Pathania, Alan D'Andrea, István Csabai, Shib Srivast, Matthew Freedman, Albert Dobi, Sandor Spisak
We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies. In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 ( CHD1 ) loss on prostate cancer tissue microarrays. We created CRISPR edited, CHD1 deficient prostate cancer cell lines for genomic, drug sensitivity and functional homologous recombination (HR) activity analysis...
April 1, 2024: Research Square
https://read.qxmd.com/read/38643762/stat3-regulates-developmental-hematopoiesis-and-impacts-myeloid-cell-function-via-canonical-and-non-canonical-modalities
#56
JOURNAL ARTICLE
Mohamed Luban Sobah, Clifford Liongue, Alister C Ward
Signal transducer and activator of transcription (STAT) 3 is extensively involved in the development, homeostasis and function of immune cells, with STAT3 disruption associated with human immune-related disorders. These roles have been assumed to be due to its canonical mode of action as an inducible transcription factor downstream of multiple cytokines, although alternative non-canonical functional modalities have also been described for STAT3. To further understand the roles of STAT3 gained from lineage-specific mouse knockouts, CRISPR/Cas9 was used to generate mutants of the conserved zebrafish Stat3 protein: a loss of function knockout (KO) mutant and a mutant lacking C-terminal sequences including the transactivation domain (ΔTAD)...
April 20, 2024: Journal of Innate Immunity
https://read.qxmd.com/read/38643711/generation-of-a-ppm1a-deficient-human-induced-pluripotent-stem-cell-line-using-crispr-cas9-technology
#57
JOURNAL ARTICLE
Xinrui Guo, Kui Zhao, Yanqi Zhang, Tiancheng Zhou, Guangjin Pan
PPM1A is a member of the serine/threonine protein phosphatase family. It can bind to a variety of proteins to dephosphorylate them, and extensively regulates many life activities such as cell growth, cell stress, immune response, and tumor formation. Here we constructed a human induced pluripotent stem cell (hiPSC) line with knockout of PPM1A using CRISPR/Cas9-mediated gene targeting. This cell line exhibits normal karyotype, pluripotency, and trilineage differentiation potential, which could provide a useful cellular resource for exploring the mechanism of PPM1A in regulating downstream signaling pathways and explore the application of PPM1A in anti-tumor and anti-infection...
April 12, 2024: Stem Cell Research
https://read.qxmd.com/read/38643181/high-glucose-induced-p66shc-mitochondrial-translocation-regulates-autophagy-initiation-and-autophagosome-formation-in-syncytiotrophoblast-and-extravillous-trophoblast
#58
JOURNAL ARTICLE
Lulu Ji, Xiaoli Zhang, Zhiguo Chen, Yuexiao Wang, Hengxuan Zhu, Yaru Nai, Yanyi Huang, Rujie Lai, Yu Zhong, Xiting Yang, Qiongtao Wang, Hanyang Hu, Lin Wang
BACKGROUND: p66Shc, as a redox enzyme, regulates reactive oxygen species (ROS) production in mitochondria and autophagy. However, the mechanisms by which p66Shc affects autophagosome formation are not fully understood. METHODS: p66Shc expression and its location in the trophoblast cells were detected in vivo and in vitro. Small hairpin RNAs or CRISPR/Cas9, RNA sequencing, and confocal laser scanning microscope were used to clarify p66Shc's role in regulating autophagic flux and STING activation...
April 20, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38642550/myosin-inhibitor-reverses-hypertrophic-cardiomyopathy-in-genotypically-diverse-pediatric-ipsc-cardiomyocytes-to-mirror-variant-correction
#59
JOURNAL ARTICLE
Caroline Kinnear, Abdelrahman Said, Guoliang Meng, Yimu Zhao, Erika Y Wang, Naimeh Rafatian, Neha Parmar, Wei Wei, Filio Billia, Craig A Simmons, Milica Radisic, James Ellis, Seema Mital
Pathogenic variants in MYH7 and MYBPC3 account for the majority of hypertrophic cardiomyopathy (HCM). Targeted drugs like myosin ATPase inhibitors have not been evaluated in children. We generate patient and variant-corrected iPSC-cardiomyocytes (CMs) from pediatric HCM patients harboring single variants in MYH7 (V606M; R453C), MYBPC3 (G148R) or digenic variants (MYBPC3 P955fs, TNNI3 A157V). We also generate CMs harboring MYBPC3 mono- and biallelic variants using CRISPR editing of a healthy control. Compared with isogenic and healthy controls, variant-positive CMs show sarcomere disorganization, higher contractility, calcium transients, and ATPase activity...
April 16, 2024: Cell reports medicine
https://read.qxmd.com/read/38640836/parp-inhibitors-suppress-tumours-via-centrosome-error-induced-senescence-independent-of-dna-damage-response
#60
JOURNAL ARTICLE
Wei Yue, Xinyu Li, Xiaolu Zhan, Lei Wang, Jihong Ma, Meiyu Bi, Qilong Wang, Xiaoyang Gu, Bingteng Xie, Tong Liu, Hongyan Guo, Xin Zhu, Chen Song, Jie Qiao, Mo Li
BACKGROUND: Poly(ADP-ribose) polymerase (PARP) inhibitors have emerged as promising chemotherapeutic drugs primarily against BRCA1/2-associated tumours, known as synthetic lethality. However, recent clinical trials reported patients' survival benefits from PARP inhibitor treatments, irrelevant to homologous recombination deficiency. Therefore, revealing the therapeutic mechanism of PARP inhibitors beyond DNA damage repair is urgently needed, which can facilitate precision medicine. METHODS: A CRISPR-based knock-in technology was used to establish stable BRCA1 mutant cancer cells...
April 18, 2024: EBioMedicine
keyword
keyword
79547
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.